Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.35 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.35 |
| ▸ | ITGAL | P20701 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.33 |
| ▸ | KIF11 | P52732 | 1/20 | 0.33 |
| ▸ | RARA | P10276 | 2/20 | 0.33 |
| ▸ | RARB | P10826 | 2/20 | 0.33 |
| ▸ | RARG | P13631 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | CRHBP | P24387 | 2/20 | 0.32 |
| ▸ | CRHR2 | Q13324 | 2/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | LDHA | P00338 | 1/20 | 0.32 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22755210 | 0.80 | ITGB2 (0.40) | KMT2AITGB2ICAM1ITGALSMN1; SMN2 | |
| SCHEMBL21757641 | 0.80 | AKR1B1 (0.51) | KMT2AKIF11RARARARBRARG | |
| SCHEMBL21757625 | 0.77 | HDAC4 (0.33) | — | |
| SCHEMBL7136823 | 0.76 | ITGB2 (0.39) | KMT2AITGB2ICAM1ITGALSMN1; SMN2 | |
| SCHEMBL2632863 | 0.72 | ITGB2 (0.46) | KMT2AITGB2ICAM1ITGALSMN1; SMN2 | |
| SCHEMBL3428659 | 0.72 | KMT2A (0.36) | KMT2AITGB2ICAM1ITGALSMN1; SMN2 | |
| SCHEMBL24162776 | 0.71 | ITGB2 (0.44) | KMT2AITGB2ICAM1ITGALSMN1; SMN2 | |
| SCHEMBL19577941 | 0.70 | KDM1A (0.47) | KMT2AAKR1B1 | |
| SCHEMBL17729317 | 0.69 | ITGB2 (0.43) | KMT2AITGB2ICAM1ITGALSMN1; SMN2 | |
| SCHEMBL30403463 | 0.69 | ITGB2 (0.43) | KMT2AITGB2ICAM1ITGALSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3215509-B1 | SUBSTITUTED PYRROLO[1,2-A]PYRIMIDINES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS | LYSOSOMAL THERAPEUTICS INC (US) | 2020-02-26 | — | — | EP | disclosed |